TABLE V.
Study | No. of cases | No. of controls | Frequency in cases | Frequency in controls | OR | 95% CI | P-value |
---|---|---|---|---|---|---|---|
African ancestry | |||||||
Bunker et al. 2,3 (Tobago men) | 343 | 426 | 0.05 | 0.06 | 0.83 | 0.53–1.29 | 0.40 |
Robbins et al. 14 (African Americans) | 567 | 490 | 0.08 | 0.11 | 1.4 (associated with G allele) | 0.9–2.4 | 0.123 0.068 (adju. for age and W.A. ancestry) |
Cheng et al. 15 (African Americans) | 89 | 89 | 0.09 | 0.11 | 1.15 (associated with G allele) | 0.57–2.35 | 0.693 |
Salinas et al. 16 (African Americans) | 145 | 78 | 0.57 | 0.28–1.18 | 0.13 |
No. of cases | No. of controls | G allele | G allele | OR (GT genotype) | OR (GG genotype) | P-value | |
---|---|---|---|---|---|---|---|
European ancestry | |||||||
Yeager et al. 13 PLCO (G) | 1,172 | 1,157 | 0.55 | 0.49 | 1.40 (1.14–1.73) | 1.73 (1.37–2.19) | 2.43 × 10−5 |
Yeager et al. 13 ACS | 1,140 | 1,151 | 0.55 | 0.50 | 1.27 (1.03–1.56) | 1.49 (1.18–1.89) | 3.16 × 10−3 |
Yeager et al. 13 ATBC | 894 | 896 | 0.57 | 0.51 | 1.26 (0.99–1.60) | 1.66 (1.28–2.16) | 1.89 × 10−3 |
Yeager et al. 13 FPCC | 455 | 459 | 0.56 | 0.51 | 1.13 (0.81–1.59) | 1.45 (1.00–2.10) | 1.17 × 10−1 |
Yeager et al. 13 HPFS | 625 | 636 | 0.57 | 0.51 | 1.15 (0.87–1.53) | 1.58 (1.15–2.16) | 9.54 × 10−3 |
Yeager et al. 13 ALL | 4,284 | 4,299 | 0.56 | 0.50 | 1.26 (1.13–1.41) | 1.58 (1.40–1.78) | 9.42 × 10−13 |
Cheng et al. 15 (European Americans) (G) | 417 | 417 | 0.56 | 0.50 | 1.39 | 1.14–1.70 | 0.001 |
Salinas et al. 16 (Caucasians) | 1,258 | 1,238 | 0.45 | 0.50 | 0.91 (0.75–1.10) (GT genotype) | 0.67 (0.54–0.85) (TT genotype) | 0.0017 |